Global Retirement Partners LLC Sells 313 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Global Retirement Partners LLC cut its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 32.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 649 shares of the medical device company’s stock after selling 313 shares during the period. Global Retirement Partners LLC’s holdings in Cooper Companies were worth $60,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Fulton Bank N.A. grew its position in Cooper Companies by 3.0% in the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after acquiring an additional 109 shares during the period. Mather Group LLC. grew its position in Cooper Companies by 7.4% in the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock valued at $177,000 after acquiring an additional 133 shares during the period. MassMutual Private Wealth & Trust FSB grew its position in Cooper Companies by 15.6% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after acquiring an additional 136 shares during the period. Greenleaf Trust grew its position in Cooper Companies by 5.0% in the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock valued at $268,000 after acquiring an additional 139 shares during the period. Finally, UMB Bank n.a. grew its position in Cooper Companies by 22.5% in the fourth quarter. UMB Bank n.a. now owns 773 shares of the medical device company’s stock valued at $71,000 after acquiring an additional 142 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Trading Up 0.6 %

Shares of COO opened at $90.38 on Friday. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 12-month low of $84.76 and a 12-month high of $112.38. The firm has a market capitalization of $18.04 billion, a PE ratio of 46.35, a price-to-earnings-growth ratio of 2.25 and a beta of 1.00. The stock’s fifty day simple moving average is $92.64 and its 200-day simple moving average is $99.48.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same quarter in the prior year, the firm posted $0.87 earnings per share. The firm’s revenue for the quarter was up 9.8% compared to the same quarter last year. As a group, research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have commented on COO. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Citigroup reduced their price objective on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research note on Friday, December 6th. Wells Fargo & Company boosted their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Finally, Morgan Stanley reduced their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Friday, December 6th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat.com, Cooper Companies has an average rating of “Moderate Buy” and a consensus target price of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.